Pliant Therapeutics Inc (PLRX)

Dec 19, 2025

Can Pliant Therapeutics Inc. stock double in next 5 yearsTrade Volume Summary & Long-Term Safe Investment Ideas - DonanımHaber

Dec 19, 2025

Dec 19, 2025

Pliant Therapeutics appoints Minnie Kuo as COO - MSN

Dec 19, 2025

Dec 19, 2025

Is Pliant Therapeutics Inc. (9PT) stock prepared for digital transition2025 Buyback Activity & Verified Chart Pattern Signals - Улправда

Dec 19, 2025

Dec 17, 2025

Is Pliant Therapeutics Inc a good long term investmentHead and Shoulders Patterns & Free Professional Investment Consultations - earlytimes.in

Dec 17, 2025

Dec 17, 2025

What analysts say about Pliant Therapeutics Inc stockStock Screening Results & Free Explosive Wealth Accumulation - earlytimes.in

Dec 17, 2025

Dec 17, 2025

Pliant Therapeutics appoints Minnie Kuo as chief operating officer By Investing.com - Investing.com Nigeria

Dec 17, 2025

Dec 16, 2025

Pliant Therapeutics appoints Minnie Kuo as chief operating officer - Investing.com

Dec 16, 2025

Dec 16, 2025

Pliant Therapeutics Appoints Minnie Kuo as COO - TipRanks

Dec 16, 2025

Dec 16, 2025

Pliant Therapeutics Appoints New Chief Operating Officer - TradingView — Track All Markets

Dec 16, 2025

Dec 16, 2025

Pliant Therapeutics (NASDAQ: PLRX) names Minnie Kuo Chief Operating Officer - Stock Titan

Dec 16, 2025

Dec 11, 2025

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Average Rating of “Reduce” by Brokerages - Defense World

Dec 11, 2025

Dec 11, 2025

Pliant Therapeutics, Inc. (NASDAQ:PLRX) Given Average Rating of "Reduce" by Brokerages - MarketBeat

Dec 11, 2025

Dec 09, 2025

Pliant Therapeutics, Inc. (PLRX) Presents at Piper Sandler 37th Annual Healthcare ConferenceSlideshow - Seeking Alpha

Dec 09, 2025

Dec 08, 2025

Pliant Therapeutics to end employment of chief medical officer Dr. Éric Lefebvre - Investing.com Nigeria

Dec 08, 2025

Dec 08, 2025

Pliant Therapeutics Announces Departure of Chief Medical Officer - TradingView

Dec 08, 2025

Dec 08, 2025

Pliant Therapeutics Inc (PLRX) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews

Dec 08, 2025

Dec 08, 2025

Pliant Therapeutics to end employment of chief medical officer Dr. Éric Lefebvre By Investing.com - Investing.com South Africa

Dec 08, 2025

Dec 07, 2025

Pliant Therapeutics shares rise after early cancer drug data impresses - MSN

Dec 07, 2025

Dec 06, 2025

Pliant Therapeutics (PLRX) Stock Analysis Report | Financials & Insights - Benzinga

Dec 06, 2025

Dec 05, 2025

Pliant Therapeutics reports interim PLN-101095 Phase I trial data - Yahoo

Dec 05, 2025

Dec 05, 2025

Pliant’s PLN-101095 shows promising results in cancer trial By Investing.com - Investing.com Nigeria

Dec 05, 2025

Dec 05, 2025

Can Pliant Therapeutics Inc. stock sustain revenue growthJuly 2025 PreEarnings & Real-Time Volume Trigger Notifications - Newser

Dec 05, 2025

Dec 05, 2025

Analysts Offer Insights on Healthcare Companies: Pliant Therapeutics (PLRX), uniQure (QURE) and Medtronic (MDT) - The Globe and Mail

Dec 05, 2025

Dec 05, 2025

What hedge fund moves indicate for Pliant Therapeutics Inc. (9PT) stockJuly 2025 Review & Free Safe Capital Growth Stock Tips - Newser

Dec 05, 2025

Dec 04, 2025

Can Pliant Therapeutics Inc. (9PT) stock double in coming yearsJuly 2025 Snapshot & Risk Controlled Daily Trade Plans - Newser

Dec 04, 2025

Dec 04, 2025

Why Pliant Therapeutics Inc. (9PT) stock could be top winnerBear Alert & Risk Controlled Daily Plans - Newser

Dec 04, 2025

Dec 04, 2025

Why Is Pliant Therapeutics Stock Trading Lower TodayPliant Therapeutics (NASDAQ:PLRX) - Benzinga

Dec 04, 2025

Dec 04, 2025

Pliant Therapeutics, Inc. (PLRX) -15.3% in Intraday Trading: Interim Data Announcement Fails to Support Price - Stocks Telegraph

Dec 04, 2025

Dec 04, 2025

Pliant Therapeutics stock jumps on promising cancer drug trial results By Investing.com - Investing.com South Africa

Dec 04, 2025

Dec 04, 2025

Pliant Therapeutics stock jumps on promising cancer drug trial results - Investing.com

Dec 04, 2025

Dec 04, 2025

Pliant Therapeutics, Inc. Announces Interim Data from Pln-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors - marketscreener.com

Dec 04, 2025

Dec 04, 2025

Pliant’s PLN-101095 shows promising results in cancer trial - Investing.com India

Dec 04, 2025

Dec 04, 2025

Pliant Therapeutics reveals promising early results for PLN-101095 - Traders Union

Dec 04, 2025

Dec 04, 2025

Pliant Therapeutics announces interim data from PLN-101095 - marketscreener.com

Dec 04, 2025

Dec 04, 2025

Pliant Therapeutics (Nasdaq: PLRX) reports interim PLN-101095 data with 1 CR, 3 PRs - Stock Titan

Dec 04, 2025

Dec 04, 2025

Pliant Therapeutics Announces Interim Data from PLN-101095 in Patients with Immune Checkpoint Inhibitor-Refractory Advanced Solid Tumors - Sahm

Dec 04, 2025

Dec 04, 2025

Is Pliant Therapeutics Inc. (9PT) stock considered safe havenTrade Volume Report & Community Consensus Stock Picks - Newser

Dec 04, 2025

Dec 03, 2025

Are Smart Investors Making the Right Decision? Pliant Therapeutics Inc (PLRX) - setenews.com

Dec 03, 2025

Dec 03, 2025

Will Pliant Therapeutics Inc. (9PT) stock profit from fiscal stimulusMarket Risk Summary & Verified Swing Trading Watchlist - Newser

Dec 03, 2025

Dec 03, 2025

Will Pliant Therapeutics Inc. stock attract more institutional investors - Newser

Dec 03, 2025

Dec 01, 2025

Pliant Therapeutics to Participate in the Piper Sandler Healthcare Conference - Investing News Network

Dec 01, 2025

Dec 01, 2025

Pliant Therapeutics Inc Stock Analysis and ForecastRSI Overbought/Oversold & Insights From Wall Street Professionals - earlytimes.in

Dec 01, 2025

Nov 28, 2025

What drives Pliant Therapeutics Inc stock priceCapital Gains Strategies & Access Advanced Stock Screening Tools - earlytimes.in

Nov 28, 2025